At Jacobs, we’re working towards a better future – for us all.
Together We Transform
For more than 70 years, Jacobs has assembled the best teams on the planet to overcome challenges no one else can. With a laser-like focus on innovation, we partner with the world’s leading Life Sciences firms to advance transformative treatments and therapies. We design, build, qualify and commission leading-edge, manufacturing facilities that positively impact people’s lives and shape a better tomorrow.
life sciences projects, representing $50B+ in construction costs
ISPE Facility of the Year Awards since 2010
ENR Overall & Design Firm Global and Pharmaceuticals
We’re supporting our biopharma clients to bring innovative products to market at pace. With a relentless focus on safety, quality and cost, our diverse, global teams and Subject Matter Experts (SMEs) deploy an integrated project delivery (IPD) approach and leverage cutting-edge digital tools to deliver ‘first of a kind’ facilities within accelerated timelines. In this rapidly evolving environment, we’re supporting clients to deliver projects in these emerging areas:
Messenger RNA (mRNA)
mRNA is a rapidly evolving area of medicine with huge potential. United by a sense of shared purpose, we’re working with our biopharma clients, deploying creative thinking and high-level problem solving to accelerate the development and delivery of potentially transformative treatments. The delivery of facilities that are designed for higher production volumes and make treatments accessible to more patients is a crucial step towards revolutionizing modern medicine.
As the commercialization of autologous cell-therapy products gathers pace, wider access is becoming a reality. To ensure more people around the world can access these innovative treatments, we are partnering with clients to overcome operational and regulatory challenges as they scale out production.
With an increasing number of cell and gene therapy products receiving regulatory approval, there is a burning need to deliver projects that support the growth of groundbreaking treatments. We’re working hand-in-hand with clients to provide a flexible approach to facility design that addresses complex challenges as manufacturers ramp up production capacity.
Contract development and manufacturing organizations (CDMOs) are supporting a seismic shift in Life Sciences, with their highly flexible large-scale facilities increasing production capacity on a massive scale, reducing risk for pharma companies, and guaranteeing hyper-speed project delivery. We’re helping CDMO clients reach these previously unattainable production targets with a flexible approach realized using integrated project delivery (IPD).
Flexibility played a central role in the response to COVID-19, with solutions providers and Life Sciences companies working together at lightning speed to retro-fit existing facilities for vaccines and treatments. This approach is helping to futureproof the sector, enabling companies to scale manufacturing in response to evolving patient needs, providing fast-tracked access to potentially transformative medicines treatments and therapies for patients globally and addressing patient demand for new treatments and therapies.
“Every day when I go to work, I’m focused on the fact that we’re all doing this for the patients. The facilities that we design and build on behalf of clients will produce medicine that may ultimately save lives.”
Meet the Team Transforming Life Sciences
Read more about the talent who make it happen every day.
Vice President & General Manager, Life Sciences
Vice President, Life Sciences, North America
Vice President, Life Sciences, India and Asia
Vice President, Life Sciences, Europe
Vice President, Global Growth & Strategy, Life Sciences
Director of Life Sciences Operations, Denmark
Jacobs Senior Architectural Technologist and Subject Matter Expert John Chapman shares the purpose that drives his work in designing manufacturing facilities for pharmaceutical and bio-pharmaceutical products.
Director of Commissioning, Qualification and Validation for Jacobs Life Sciences North America Judith Kozak shares how a family health scare serves as a daily reminder of the life-changing impact Jacobs has.
Director of Process Engineering for Jacobs’ Conshohocken Life Sciences operation Dhruv Kapoor shares how enabling access to healthcare in countries all over the world motivates him every day.
Jacobs Senior Principal Architect, Monika Verma, shares a personal story of how her work designing pharmaceutical facilities for research and development and the manufacturing of medicines for people around the world has impacted her personally.
Lead Piping Engineer Parimal Trivedi shares his personal experience of how modern medicine has transformed his family’s life.
Jacobs Piping Section Manager, Priya Unni, weighs in on our culture at Jacobs and how our Life Sciences team inspires her everyday.
Our work continues to positively impact millions of lives with significant projects and programs around the globe.
“The transformative nature of the treatments and therapies our clients manufacture means our team is deeply invested and passionate about the work we do. This sense of purpose is embedded in every project we deliver. We’re united in our commitment to making sure more patients around the world gain access to life-enhancing medicines.”
WuXi Biologics Drug Substance Manufacturing Facility
WuXi Biologics’ state of the art biopharmaceutical plant in Dundalk, Ireland is one of the largest single-use bioreactors-based facilities in Europe. Notably, it is also WuXi Biologics’ first greenfield biopharmaceutical facility outside China.
Jacobs Chosen by Spark Therapeutics to Build Gene Therapy Innovation Center
Jacobs was awarded an engineering, procurement and construction management contract with Spark Therapeutics, Inc. (Spark) to build its Gene Therapy Innovation Center in the University City area of West Philadelphia. When complete, the multi-story facility will serve as a global center of excellence for gene therapy manufacturing and advance the science of gene therapy.
Bristol Myers Squibb Large-Scale Cell Culture Manufacturing Facility
Bringing life-saving pharmaceutical treatments to the market for tomorrow
Jacobs Wins Mark Cuban Cost Plus Drug Company, PBC Contract to Deliver Pharmaceutical Facility
Jacobs was selected to provide Engineering services for Mark Cuban Cost Plus Drug Company, PBC’s facility in Dallas, Texas. The facility will provide low-cost versions of high-cost generic drugs. Find out more about this facility, and Jacobs' involvement, in this article.
Edwards Lifesciences Greenfield Manufacturing Facility
Supplying Europe with critical heart valve technologies just got a bit easier with completion of Edwards Lifesciences’ new Gold LEED-certified manufacturing facility in Ireland’s National Technology Park just outside Limerick. Recipient of the 2022 Irish Construction Excellence Award in the “Industrial Over €15m” category, it was constructed using an Integrated Project Delivery (IPD) procurement approach and innovative digital tools.
You might be interested in...
From our newsroom
Leading With Purpose: A Q&A with Director of Life Sciences Operations for Denmark, Lene Bjerregaard
Leveraging expertise built during her 25-year career, Director of Life Sciences Operations for Denmark, Lene Bjerregaard, is driving sustainable growth at our new Danish base.
Setting the Standard for Pharma Facilities of the Future
The Pfizer Biotechnology Center in Hangzhou, China – designed by us – nabbed two ISPE Facility of the Year awards.
Q&A: Talking with Subject Matter Expert and Lead Process Engineer, Life Sciences, Julie Vickers
Working at the forefront of life sciences, Subject Matter Expert (SME) and Lead Process Engineer Julie Vickers deploys creative thinking and high-level problem solving to turn design concepts into next-generation cell and gene therapy and mRNA facilities. We interviewed Julie about trends in facility design, how mRNA has the potential to transform product delivery and the importance of diverse, inclusive teams to drive innovation.
Sustainable, Safe and State-of-the-Art: Biocon Biologics’ New Bangalore Facility Receives Recognition
Jacobs-delivered Biocon Biologics’ new flexible facility, one of the largest in India and an honorable mention for Facility of the Year
Powering Progress in Life Sciences: A Q&A with Peter Cramer, AIA Subject Matter Expert and Principal Process Architect
With advances in mRNA set to usher in changes in modern medicine, Peter Cramer discusses how we support clients to overcome challenges in this rapidly evolving field and deliver first-of-a-kind projects.
Advancing the Facilities of the Life Sciences Industry
Advances in medicine over the past 30 years have extended and improved the quality of life for people around the world. In this episode of Inflection Points, John Noble, Jacobs Vice President and General Manager, Life Sciences talks about the life sciences industry and how integrated project management helps firms get their facilities done on time.
Q&A: Talking with Jacobs’ Ohio AstraZeneca Retrofit Team
We connected with Jacobs’ Lindsay Gerding, Mayme Brusoe and Amy Gardner to talk career, their project with AstraZeneca shaping a potential COVID-19 vaccine and what they enjoy about being part of #OurJacobs. Read more in their Jacobs.com interview.
Jacobs Wins Contract to Provide Construction Phase Services for WuXi Biologics Biomanufacturing Facility
Jacobs has been selected to provide construction management services for global biologics leader, WuXi Biologics, to support the development of its new biologics drug substance manufacturing facility located in Dundalk, Co. Louth, Ireland. The new facility, modelled on the "Factories of the Future" concept, will incorporate best-in-class innovative technology optimized for the flexible production of a wide range of biologic drugs for customers globally.
In the media
Overcoming Operational and Regulatory Challenges in Autologous Cell-Therapy Facilities
Manufacturers must address scale-out challenges of autologous cell therapy for commercial manufacturing. Jacobs' Francesca McBride covers this topic in Pharmaceutical Technology.
Engineering Angles: A flexible future
Jacobs' Brian Ribnicky shares his thoughts on overcoming operational challenges in cell and gene therapy production in Pharma Manufacturing.
Engineering Angles: Fast-tracking access to treatments
How are How CDMOs are supporting a paradigm shift in pharma manufacturing? Jacobs' John Noble discusses with Pharma Manufacturing.
Achieving the ‘design one, build many’ paradigm
Jacobs' John Noble discussed how diversity and digitization can help fast-track CDMO projects with Pharma Manufacturing.
Designing Flexible Fill/Finish Facilities
Scenario modeling informs planning for current and future manufacturing needs. Jacobs' Jorge Ferreira and Lora Zeanchock discuss this concept and more in BioPharm International.
Fujifilm picks Jacobs Engineering for $2B Holly Springs Project
Triangle Business Journal provides details on Jacobs' selection by Fujifilm for its new project.
Rendering courtesy of FUJIFILM DIOSYNTH
Controlling Quality in Aging Facilities
Manufacturing biopharmaceuticals in an aging facility may create quality issues such as equipment breakdown and contamination risks. BioPharm International explores this topic.
Together, We Transform
Jacobs' John Noble shares how Jacobs' Life Sciences team operates at the cutting edge of science and technology to help save lives.
How The Bio-pharma Sector’s Quest to Combat COVID-19 is Transforming Project Delivery
Jacobs' John Noble shares a winning formula for project delivery in the age of accelerated project delivery.
Irish Building Magazine: Meet Irish Construction Excellence’s Industry Contribution Award Recipient, Jim Hayde (page 116)
Irish Examiner: Cliona Kennedy: Teamwork at Heart of Engineering Projects
Engineers Ireland: Why I Became An Engineer: Elaine Clarke, Process Engineer, Jacobs
Engineers Ireland: Why I Became An Engineer: Katie Kilcoyne, Process Engineer, Jacobs
ICE Awards 2022: Industrial Over €15m - Edwards Lifesciences Greenfield Manufacturing Facility, Limerick
ISPE FOYA 2020: 2020 FOYA Category Winner for Facility of the Future & Overall Winner - Sanofi
ISPE FOYA 2019: 2019 Category Winner for Project Execution - Pfizer
“I was part of a team that conducted engineering and homogeneity studies to ensure that the drugs being manufactured at a client facility complied with the exact same high standard. I could never have imagined how much those drugs would one day change my life. Every time I think about the projects I work on; I am overcome with an overwhelming sense of pride. It’s a real-life reminder of how much our work positively impacts lives, including our own.”